Dose study of the multikinase inhibitor, LY2457546, in patients with relapsed acute myeloid leukemia to assess safety, pharmacokinetics, and pharmacodynamics. - Wacheck V; Lahn M; Dickinson G; Füreder W; Meyer R; Herndlhofer S; Füreder T; Dorfner G; Pillay S; André V; Burkholder TP; Akunda JK; et al. (Cancer management and research, 2011)